About Biovision

The Forum

Biovision World Life Science Forum is fostering a unique approach to meet,connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors.

Biovision 2016 pattern is dedicated to strengthen Action & Interaction for Innovation with:


Didier Hoch
Chairman of Biovision forum

Presenting an impressive line-up of participants addressing evidence and research as well as development and promotion, the 2016 edition of the BIOVISION life sciences forum affirms its status as a standout gathering of knowledge among other such international meetings. This year, the forum will welcome major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance) with the goal of arriving at concrete solutions to existing and future health issues.

schema

prospective

A meeting place for stakeholders in global health
The Prospective meetings will facilitate discussions between BIOVISION participants, international experts and leading figures in global health and prevention throughout the course of four main session focusing on the following themes: Medicine and Humanities, Future Vaccines, Cancer prevention : challenges and opportunities, The Digital Patient. During each session, twenty to thirty experts will participate and exchange ideas in workshops. Their conclusions will be presented at plenary session and finalized within the Call for action addressed to the international community at BIOVISIONís closing ceremony.

Catalyzer

A springboard for innovative health projects and start-ups
Innovators in the fields of Biotech, Medtech, e-health and environmental health may hold the solutions to the health issues of today and tomorrow. BIOVISION is committed to discovering these individuals, supporting them by putting their ideas in the spotlight, and placing them on the fast track towards the fulfilment and realisation of their work. During the Catalyzer meetings, these pioneers in emerging health fields will have the opportunity to pitch their proposals to an expert committee comprised of academic, industry and civil society partners for the chance to develop future collaborations as well as further implementation of their projects.

IC

The intersection of health start-ups and venture capital
The Investor Conference accelerates the fundraising process of Biotech, Medtech, e-health and environmental health start-ups by putting them in direct contact with potential business and development partners. Selected from a pool of applicants by a special committee, start-ups with the greatest potential to offer innovative health solutions will present their pitches during the BIOVISION forum in front of a jury comprised of leading European private and corporate investors in the life sciences. .